New ultrasound tech could spot hidden placental problems in pregnancy

NCT ID NCT06861309

Recruiting now Knowledge-focused Sponsor: Carilion Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing two new ultrasound techniques to see if they can tell the difference between healthy pregnancies and those affected by fetal growth restriction (FGR), where the baby is smaller than expected. Researchers will scan 60 pregnant women every three weeks using a special research ultrasound machine. The goal is to find out if these methods can detect early signs of placental insufficiency, which can lead to serious complications like preeclampsia or stillbirth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a better way to monitor at-risk pregnancies and catch problems like poor fetal growth early.
What could go wrong: This is a small, early-stage study. The new imaging techniques may not prove reliable enough for routine use, and results may not apply to all pregnancies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FETAL GROWTH RESTRICTION (FGR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction placental insufficiency preeclampsia pregnancy disorder pregnancy disorder with abortive outcome Stillbirth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FETAL GROWTH RESTRICTION (FGR) PLACENTAL INSUFFICIENCY PREECLAMPSIA PREGNANCY PREGNANCY COMPLICATIONS PREGNANCY OUTCOMES STILL BIRTHS ULTRASOUND

Contacts and locations

Locations

Carilion Clinic Maternal Fetal Medicine
RECRUITING

Roanoke, Virginia, 24013, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.